Imunon, Inc. — Director's Dealing 2012

Jun 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-06-15

Reporting Person: WEAVER GREGORY L (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-15	Option to purchase Celsion Corporation Common Stock	$2.15	A	36250	Acquired	2022-06-15	Celsion Corporation Common Stock (36250)	Direct

Footnotes

F1: The Option vests in thirds over three years on the anniversary date of the option grant.

F2: Represents the closing price of Celsion Corporation Common Stock on the date of the grant.